Institutional Ownership
Tiziana Life Sciences Ltd
CUSIP G88912103COMMON SHARESTLSAQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
32
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Dauntless Investment Group, LLC | 2.17M | $2.53M |
| 2 | Marshall Wace, LLP | 157.6K | $184.4K |
| 3 | Zhang Financial LLC | 111.9K | $130.9K |
| 4 | Ubs Group AG | 95.7K | $112.0K |
| 5 | Focus Partners Wealth | 79.4K | $92.9K |
| 6 | Geode Capital Management, LLC | 78.2K | $91.5K |
| 7 | Goldman Sachs Group Inc | 75.7K | $88.5K |
| 8 | Hsbc Holdings PLC | 62.4K | $75.5K |
| 9 | Morgan Stanley | 52.2K | $61.0K |
| 10 | Ewa, LLC | 45.9K | $53.8K |